世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

バイオサージェリー用シーラントと止血剤の世界市場インサイト、2028年までの予測


Global Biosurgery Sealants and Hemostats Market Insights, Forecast to 2028

市場の分析と洞察。バイオサージェリー用シーラントと止血剤の世界市場 COVID-19の流行により、バイオサージェリーシーラントと止血剤の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年3月4日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場の分析と洞察。バイオサージェリー用シーラントと止血剤の世界市場
COVID-19の流行により、バイオサージェリーシーラントと止血剤の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年にバイオサージェリーシーラントと止血剤の世界市場の%を占めた止血剤は、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に改訂された%のCAGRで成長すると予測されます。病院セグメントは、この予測期間を通して%CAGRに変更されている間。

中国Biosurgery Sealants and Hemostatsの市場規模は2021年にUS$百万と評価され、米国と欧州Biosurgery Sealants and HemostatsはUS$百万とUS$百万、Severallyです。米国の割合は2021年に%、中国とヨーロッパはそれぞれ%と%であり、中国の割合は2028年に%に達すると予測され、分析期間を通じてCAGR%であることを追跡しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%である。ヨーロッパのバイオサージェリーシーラントとヘモスタットの展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中にCAGR %を推移しています。
バイオサージェリーシーラントと止血剤の世界の主要メーカーは、CR Bard、Johnson & Johnson、Baxter International、Medtronic、CSL Behring、CryoLife、Cothera Medical、Sanofi、Pfizerなどです。2021年、世界の上位5社は売上高で約 % のシェアを持っています。

世界のバイオサージェリー用シーラントと止血剤の範囲とセグメント
生体手術用シーラントおよび止血剤の市場は、タイプ別および用途別に区分されます。バイオサージェリーシーラントと止血剤の世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
止血剤
組織内シーラント
接着剤バリア
用途別セグメント
病院
診療所と外傷センター
外来手術センター

会社別
CRバルド
ジョンソン・エンド・ジョンソン
バクスター・インターナショナル
メドトロニック
CSLベーリング
クライオライフ
コヘラメディカル
サノフィ
ファイザー

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE


ページTOPに戻る


目次

1 Study Coverage
1.1 Biosurgery Sealants and Hemostats Product Introduction
1.2 Market by Type
1.2.1 Global Biosurgery Sealants and Hemostats Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hemostats
1.2.3 Internal Tissue Sealants
1.2.4 Adhesion Barriers
1.3 Market by Application
1.3.1 Global Biosurgery Sealants and Hemostats Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics and Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosurgery Sealants and Hemostats Sales Estimates and Forecasts 2017-2028
2.2 Global Biosurgery Sealants and Hemostats Revenue Estimates and Forecasts 2017-2028
2.3 Global Biosurgery Sealants and Hemostats Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biosurgery Sealants and Hemostats Sales by Region
2.4.1 Global Biosurgery Sealants and Hemostats Sales by Region (2017-2022)
2.4.2 Global Sales Biosurgery Sealants and Hemostats by Region (2023-2028)
2.5 Global Biosurgery Sealants and Hemostats Revenue by Region
2.5.1 Global Biosurgery Sealants and Hemostats Revenue by Region (2017-2022)
2.5.2 Global Biosurgery Sealants and Hemostats Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biosurgery Sealants and Hemostats Sales by Manufacturers
3.1.1 Global Top Biosurgery Sealants and Hemostats Manufacturers by Sales (2017-2022)
3.1.2 Global Biosurgery Sealants and Hemostats Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosurgery Sealants and Hemostats in 2021
3.2 Global Biosurgery Sealants and Hemostats Revenue by Manufacturers
3.2.1 Global Biosurgery Sealants and Hemostats Revenue by Manufacturers (2017-2022)
3.2.2 Global Biosurgery Sealants and Hemostats Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biosurgery Sealants and Hemostats Revenue in 2021
3.3 Global Biosurgery Sealants and Hemostats Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biosurgery Sealants and Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biosurgery Sealants and Hemostats Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biosurgery Sealants and Hemostats Sales by Type
4.1.1 Global Biosurgery Sealants and Hemostats Historical Sales by Type (2017-2022)
4.1.2 Global Biosurgery Sealants and Hemostats Forecasted Sales by Type (2023-2028)
4.1.3 Global Biosurgery Sealants and Hemostats Sales Market Share by Type (2017-2028)
4.2 Global Biosurgery Sealants and Hemostats Revenue by Type
4.2.1 Global Biosurgery Sealants and Hemostats Historical Revenue by Type (2017-2022)
4.2.2 Global Biosurgery Sealants and Hemostats Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biosurgery Sealants and Hemostats Revenue Market Share by Type (2017-2028)
4.3 Global Biosurgery Sealants and Hemostats Price by Type
4.3.1 Global Biosurgery Sealants and Hemostats Price by Type (2017-2022)
4.3.2 Global Biosurgery Sealants and Hemostats Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biosurgery Sealants and Hemostats Sales by Application
5.1.1 Global Biosurgery Sealants and Hemostats Historical Sales by Application (2017-2022)
5.1.2 Global Biosurgery Sealants and Hemostats Forecasted Sales by Application (2023-2028)
5.1.3 Global Biosurgery Sealants and Hemostats Sales Market Share by Application (2017-2028)
5.2 Global Biosurgery Sealants and Hemostats Revenue by Application
5.2.1 Global Biosurgery Sealants and Hemostats Historical Revenue by Application (2017-2022)
5.2.2 Global Biosurgery Sealants and Hemostats Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biosurgery Sealants and Hemostats Revenue Market Share by Application (2017-2028)
5.3 Global Biosurgery Sealants and Hemostats Price by Application
5.3.1 Global Biosurgery Sealants and Hemostats Price by Application (2017-2022)
5.3.2 Global Biosurgery Sealants and Hemostats Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biosurgery Sealants and Hemostats Market Size by Type
6.1.1 North America Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
6.1.2 North America Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
6.2 North America Biosurgery Sealants and Hemostats Market Size by Application
6.2.1 North America Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
6.2.2 North America Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
6.3 North America Biosurgery Sealants and Hemostats Market Size by Country
6.3.1 North America Biosurgery Sealants and Hemostats Sales by Country (2017-2028)
6.3.2 North America Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Biosurgery Sealants and Hemostats Market Size by Type
7.1.1 Europe Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
7.1.2 Europe Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
7.2 Europe Biosurgery Sealants and Hemostats Market Size by Application
7.2.1 Europe Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
7.2.2 Europe Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
7.3 Europe Biosurgery Sealants and Hemostats Market Size by Country
7.3.1 Europe Biosurgery Sealants and Hemostats Sales by Country (2017-2028)
7.3.2 Europe Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biosurgery Sealants and Hemostats Market Size by Type
8.1.1 Asia Pacific Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
8.1.2 Asia Pacific Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
8.2 Asia Pacific Biosurgery Sealants and Hemostats Market Size by Application
8.2.1 Asia Pacific Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
8.2.2 Asia Pacific Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
8.3 Asia Pacific Biosurgery Sealants and Hemostats Market Size by Region
8.3.1 Asia Pacific Biosurgery Sealants and Hemostats Sales by Region (2017-2028)
8.3.2 Asia Pacific Biosurgery Sealants and Hemostats Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Biosurgery Sealants and Hemostats Market Size by Type
9.1.1 Latin America Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
9.1.2 Latin America Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
9.2 Latin America Biosurgery Sealants and Hemostats Market Size by Application
9.2.1 Latin America Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
9.2.2 Latin America Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
9.3 Latin America Biosurgery Sealants and Hemostats Market Size by Country
9.3.1 Latin America Biosurgery Sealants and Hemostats Sales by Country (2017-2028)
9.3.2 Latin America Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biosurgery Sealants and Hemostats Market Size by Type
10.1.1 Middle East and Africa Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
10.2 Middle East and Africa Biosurgery Sealants and Hemostats Market Size by Application
10.2.1 Middle East and Africa Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
10.3 Middle East and Africa Biosurgery Sealants and Hemostats Market Size by Country
10.3.1 Middle East and Africa Biosurgery Sealants and Hemostats Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CR Bard
11.1.1 CR Bard Corporation Information
11.1.2 CR Bard Overview
11.1.3 CR Bard Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CR Bard Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CR Bard Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 Baxter International
11.3.1 Baxter International Corporation Information
11.3.2 Baxter International Overview
11.3.3 Baxter International Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Baxter International Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Baxter International Recent Developments
11.4 Medtronic
11.4.1 Medtronic Corporation Information
11.4.2 Medtronic Overview
11.4.3 Medtronic Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medtronic Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medtronic Recent Developments
11.5 CSL Behring
11.5.1 CSL Behring Corporation Information
11.5.2 CSL Behring Overview
11.5.3 CSL Behring Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL Behring Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Behring Recent Developments
11.6 CryoLife
11.6.1 CryoLife Corporation Information
11.6.2 CryoLife Overview
11.6.3 CryoLife Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CryoLife Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CryoLife Recent Developments
11.7 Cohera Medical
11.7.1 Cohera Medical Corporation Information
11.7.2 Cohera Medical Overview
11.7.3 Cohera Medical Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cohera Medical Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cohera Medical Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Overview
11.9.3 Pfizer Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Pfizer Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biosurgery Sealants and Hemostats Industry Chain Analysis
12.2 Biosurgery Sealants and Hemostats Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosurgery Sealants and Hemostats Production Mode & Process
12.4 Biosurgery Sealants and Hemostats Sales and Marketing
12.4.1 Biosurgery Sealants and Hemostats Sales Channels
12.4.2 Biosurgery Sealants and Hemostats Distributors
12.5 Biosurgery Sealants and Hemostats Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biosurgery Sealants and Hemostats Industry Trends
13.2 Biosurgery Sealants and Hemostats Market Drivers
13.3 Biosurgery Sealants and Hemostats Market Challenges
13.4 Biosurgery Sealants and Hemostats Market Restraints
14 Key Findings in The Global Biosurgery Sealants and Hemostats Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Biosurgery Sealants and Hemostats Market
Due to the COVID-19 pandemic, the global Biosurgery Sealants and Hemostats market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Hemostats accounting for % of the Biosurgery Sealants and Hemostats global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Biosurgery Sealants and Hemostats market size is valued at US$ million in 2021, while the US and Europe Biosurgery Sealants and Hemostats are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Biosurgery Sealants and Hemostats landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Biosurgery Sealants and Hemostats include CR Bard, Johnson & Johnson, Baxter International, Medtronic, CSL Behring, CryoLife, Cohera Medical, Sanofi and Pfizer. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Biosurgery Sealants and Hemostats Scope and Segment
Biosurgery Sealants and Hemostats market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Biosurgery Sealants and Hemostats market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Hemostats
Internal Tissue Sealants
Adhesion Barriers
Segment by Application
Hospitals
Clinics and Trauma Centers
Ambulatory Surgical Centers

By Company
CR Bard
Johnson & Johnson
Baxter International
Medtronic
CSL Behring
CryoLife
Cohera Medical
Sanofi
Pfizer

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Biosurgery Sealants and Hemostats Product Introduction
1.2 Market by Type
1.2.1 Global Biosurgery Sealants and Hemostats Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hemostats
1.2.3 Internal Tissue Sealants
1.2.4 Adhesion Barriers
1.3 Market by Application
1.3.1 Global Biosurgery Sealants and Hemostats Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics and Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosurgery Sealants and Hemostats Sales Estimates and Forecasts 2017-2028
2.2 Global Biosurgery Sealants and Hemostats Revenue Estimates and Forecasts 2017-2028
2.3 Global Biosurgery Sealants and Hemostats Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biosurgery Sealants and Hemostats Sales by Region
2.4.1 Global Biosurgery Sealants and Hemostats Sales by Region (2017-2022)
2.4.2 Global Sales Biosurgery Sealants and Hemostats by Region (2023-2028)
2.5 Global Biosurgery Sealants and Hemostats Revenue by Region
2.5.1 Global Biosurgery Sealants and Hemostats Revenue by Region (2017-2022)
2.5.2 Global Biosurgery Sealants and Hemostats Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biosurgery Sealants and Hemostats Sales by Manufacturers
3.1.1 Global Top Biosurgery Sealants and Hemostats Manufacturers by Sales (2017-2022)
3.1.2 Global Biosurgery Sealants and Hemostats Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosurgery Sealants and Hemostats in 2021
3.2 Global Biosurgery Sealants and Hemostats Revenue by Manufacturers
3.2.1 Global Biosurgery Sealants and Hemostats Revenue by Manufacturers (2017-2022)
3.2.2 Global Biosurgery Sealants and Hemostats Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biosurgery Sealants and Hemostats Revenue in 2021
3.3 Global Biosurgery Sealants and Hemostats Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biosurgery Sealants and Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biosurgery Sealants and Hemostats Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biosurgery Sealants and Hemostats Sales by Type
4.1.1 Global Biosurgery Sealants and Hemostats Historical Sales by Type (2017-2022)
4.1.2 Global Biosurgery Sealants and Hemostats Forecasted Sales by Type (2023-2028)
4.1.3 Global Biosurgery Sealants and Hemostats Sales Market Share by Type (2017-2028)
4.2 Global Biosurgery Sealants and Hemostats Revenue by Type
4.2.1 Global Biosurgery Sealants and Hemostats Historical Revenue by Type (2017-2022)
4.2.2 Global Biosurgery Sealants and Hemostats Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biosurgery Sealants and Hemostats Revenue Market Share by Type (2017-2028)
4.3 Global Biosurgery Sealants and Hemostats Price by Type
4.3.1 Global Biosurgery Sealants and Hemostats Price by Type (2017-2022)
4.3.2 Global Biosurgery Sealants and Hemostats Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biosurgery Sealants and Hemostats Sales by Application
5.1.1 Global Biosurgery Sealants and Hemostats Historical Sales by Application (2017-2022)
5.1.2 Global Biosurgery Sealants and Hemostats Forecasted Sales by Application (2023-2028)
5.1.3 Global Biosurgery Sealants and Hemostats Sales Market Share by Application (2017-2028)
5.2 Global Biosurgery Sealants and Hemostats Revenue by Application
5.2.1 Global Biosurgery Sealants and Hemostats Historical Revenue by Application (2017-2022)
5.2.2 Global Biosurgery Sealants and Hemostats Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biosurgery Sealants and Hemostats Revenue Market Share by Application (2017-2028)
5.3 Global Biosurgery Sealants and Hemostats Price by Application
5.3.1 Global Biosurgery Sealants and Hemostats Price by Application (2017-2022)
5.3.2 Global Biosurgery Sealants and Hemostats Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biosurgery Sealants and Hemostats Market Size by Type
6.1.1 North America Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
6.1.2 North America Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
6.2 North America Biosurgery Sealants and Hemostats Market Size by Application
6.2.1 North America Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
6.2.2 North America Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
6.3 North America Biosurgery Sealants and Hemostats Market Size by Country
6.3.1 North America Biosurgery Sealants and Hemostats Sales by Country (2017-2028)
6.3.2 North America Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Biosurgery Sealants and Hemostats Market Size by Type
7.1.1 Europe Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
7.1.2 Europe Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
7.2 Europe Biosurgery Sealants and Hemostats Market Size by Application
7.2.1 Europe Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
7.2.2 Europe Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
7.3 Europe Biosurgery Sealants and Hemostats Market Size by Country
7.3.1 Europe Biosurgery Sealants and Hemostats Sales by Country (2017-2028)
7.3.2 Europe Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biosurgery Sealants and Hemostats Market Size by Type
8.1.1 Asia Pacific Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
8.1.2 Asia Pacific Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
8.2 Asia Pacific Biosurgery Sealants and Hemostats Market Size by Application
8.2.1 Asia Pacific Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
8.2.2 Asia Pacific Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
8.3 Asia Pacific Biosurgery Sealants and Hemostats Market Size by Region
8.3.1 Asia Pacific Biosurgery Sealants and Hemostats Sales by Region (2017-2028)
8.3.2 Asia Pacific Biosurgery Sealants and Hemostats Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Biosurgery Sealants and Hemostats Market Size by Type
9.1.1 Latin America Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
9.1.2 Latin America Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
9.2 Latin America Biosurgery Sealants and Hemostats Market Size by Application
9.2.1 Latin America Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
9.2.2 Latin America Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
9.3 Latin America Biosurgery Sealants and Hemostats Market Size by Country
9.3.1 Latin America Biosurgery Sealants and Hemostats Sales by Country (2017-2028)
9.3.2 Latin America Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biosurgery Sealants and Hemostats Market Size by Type
10.1.1 Middle East and Africa Biosurgery Sealants and Hemostats Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biosurgery Sealants and Hemostats Revenue by Type (2017-2028)
10.2 Middle East and Africa Biosurgery Sealants and Hemostats Market Size by Application
10.2.1 Middle East and Africa Biosurgery Sealants and Hemostats Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biosurgery Sealants and Hemostats Revenue by Application (2017-2028)
10.3 Middle East and Africa Biosurgery Sealants and Hemostats Market Size by Country
10.3.1 Middle East and Africa Biosurgery Sealants and Hemostats Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biosurgery Sealants and Hemostats Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CR Bard
11.1.1 CR Bard Corporation Information
11.1.2 CR Bard Overview
11.1.3 CR Bard Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CR Bard Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CR Bard Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 Baxter International
11.3.1 Baxter International Corporation Information
11.3.2 Baxter International Overview
11.3.3 Baxter International Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Baxter International Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Baxter International Recent Developments
11.4 Medtronic
11.4.1 Medtronic Corporation Information
11.4.2 Medtronic Overview
11.4.3 Medtronic Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medtronic Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medtronic Recent Developments
11.5 CSL Behring
11.5.1 CSL Behring Corporation Information
11.5.2 CSL Behring Overview
11.5.3 CSL Behring Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL Behring Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Behring Recent Developments
11.6 CryoLife
11.6.1 CryoLife Corporation Information
11.6.2 CryoLife Overview
11.6.3 CryoLife Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CryoLife Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CryoLife Recent Developments
11.7 Cohera Medical
11.7.1 Cohera Medical Corporation Information
11.7.2 Cohera Medical Overview
11.7.3 Cohera Medical Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cohera Medical Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cohera Medical Recent Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sanofi Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Pfizer
11.9.1 Pfizer Corporation Information
11.9.2 Pfizer Overview
11.9.3 Pfizer Biosurgery Sealants and Hemostats Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Pfizer Biosurgery Sealants and Hemostats Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biosurgery Sealants and Hemostats Industry Chain Analysis
12.2 Biosurgery Sealants and Hemostats Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosurgery Sealants and Hemostats Production Mode & Process
12.4 Biosurgery Sealants and Hemostats Sales and Marketing
12.4.1 Biosurgery Sealants and Hemostats Sales Channels
12.4.2 Biosurgery Sealants and Hemostats Distributors
12.5 Biosurgery Sealants and Hemostats Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biosurgery Sealants and Hemostats Industry Trends
13.2 Biosurgery Sealants and Hemostats Market Drivers
13.3 Biosurgery Sealants and Hemostats Market Challenges
13.4 Biosurgery Sealants and Hemostats Market Restraints
14 Key Findings in The Global Biosurgery Sealants and Hemostats Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る